Phase 2 Leukaemia Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- The participant or their guardian must be willing to voluntarily sign a written consent form agreeing to take part.
- Participants must be male or female, between 1 and 17 years old (inclusive).
- Participants must have been diagnosed with acute lymphoblastic leukemia (a type of blood cancer) according to World Health Organization standards.
- The leukemia must be in complete remission (meaning tests show no signs of active disease) before the transplant takes place.
- A suitable matched sibling donor must be available, and the participant must be willing to undergo a stem cell transplant from that sibling donor.
- Participants must have a general health score of 70 or higher on a standard medical scale, meaning they are able to care for themselves and carry out normal daily activities.
- Heart, liver, kidney, and lung function must all be within acceptable ranges, with no major organ problems (confirm specific test values with the trial site).
Who may not be able to join:
- People whose leukemia has not reached complete remission before the transplant.
- People who have chosen a donor other than a matched sibling.
- People with severe heart, liver, kidney, or lung disease that would make it unsafe to go through the pre-transplant treatment process.
- People who have an active or hard-to-treat infection, or other serious life-threatening complications.
- People with a history of another cancer, a psychiatric disorder, or HIV infection.
- People whose participant or guardian refuses to sign the consent form, is unwilling to attend required follow-up visits, or does not agree to their data being used for future research and reporting.
- People whom the trial investigators consider unsuitable for any other reason.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +86037166862278
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Relapse-free survival (RFS); acute Graft Versus Host Disease (aGVHD); Overall Survival (OS)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.